Stem Cell Banking Market 2017-2023
- September, 2017
- Domain: Healthcare - Biotechnology
- Get Free 10% Customization in this Report
Stem cells are undifferentiated biological cells that can distinguish into specialized cells, tissue, or an organ. The process of storing these stem cells for the treatment of life threatening diseases in the future is called stem cell banking. Nearly 500 stem cell banks are functioning globally, and every bank is now striving harder to increase their market share. Stem cell banking has applications in cerebral palsy, thalassemia, leukemia, diabetes, autism, and others. Cerebral palsy holds the major share of nearly quarter of the market share among the various applications. Private stem cell banks are implementing innumerable publicizing strategies to upsurge their product visibility among people.
The market is driven by factors such as easy method of extraction of stem cells from the samples, increasing birth rate, increased awareness of stem cell therapeutics, and increasing potentials of stem cell treatment. Alongside, the collaboration among the cord blood banks, increasing investments and fundings, and automation of procedures for the banking of stem cells are providing opportunities for the growth of the stem cell banking market. However, intense competition, high operating costs, changes in legal regulations, and high entry barriers are the major factors hampering the market growth.
The “Stem Cell Banking Market” is estimated to witness a CAGR of 16.4% during the forecast period 2017–2023. The market is analyzed based on three segments, namely product types, end-users, and regions.
The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is set to be the leading region for the stem cell banking market growth followed by Europe. Asia Pacific and RoW are set to be the emerging regions. India, China, and Japan are set to be the most attractive destinations due to the large untapped market.
Product Types Analysis:
The stem cell banking market by products is segmented into umbilical cord blood & cord tissue, and adult stem cell banking. The umbilical cord blood & tissue occupies the major share in the market and is also expected to grow at a fast CAGR during the forecast period. The dental stem cell banking and menstrual blood stem cell banking are the latest diversifications in the stem cell banking market. The market is also witnessing various mergers, acquisitions, and collaborations among the top players, which is defining the future of the global stem cell banking market.
Esperite, Caladrius Biosciences, Via Cord, CBR Systems, Smart Cells, Life Cell, China Cord Blood, Cryo-Cell, StemCyte, Cordvida, ViaCord, Cryoviva, and other predominate & niche players.
These days, stem cell banks exist in most of the developed and developing nations. Around 450 companies are publicizing cord blood banking services internationally, which signifies intense competition in the market. Globally, China Cord Blood Corporation (CCBC) is expected to be the fastest growing stem cell bank worldwide and in the US, it is Amricord. In 2014, the company Amricord achieved 2,200% growth rate from 2011-2013. Future Health Biobank, American Cryostem, Adicyte, Adisave, Celltex, and Vault Stem currently hold around two-thirds of the Mesenchymal Stem Cells (MSC) storage market. However, at present, these companies are still trivial but are swiftly intensifying. Cryostem witnessed its revenue to nearly double in 2016 from $400,000 to almost $800,000.
The report provides complete details about the usage and adoption rate of stem cell banking in various regions. With that, key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, government initiatives toward the stem cell therapy and banking adoption in the upcoming years along with the details of commercial devices available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Global Stem Cell Banking Market By Source Types(Umbilcal Cord Blood & Tissue Banking, Adult Stem Cell banking), By Stem Cell Bank Types (Private, Public), By region (North America, Europe, Asia-Pacific and Rest of the world) Market Trends and Drivers, Restraints, and Opportunities 2017-2023
1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market
1.3 Industry Trends
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market (SAM)
3.2.1 Evolution of Stem Cell Banking
3.2.2 Advantages of Stem Cell
3.3 Steps involved in the Stem Cell Banking
3.4 Trends of Stem Cell Banking Market
3.5 Related Addressable Markets (RAM)
3.5.1 Genome Engineering
3.5.2 Single Cell Analysis
4 Market Outlook
4.2 Market Segmentation
4.3 Porter 5(Five) Forces
4.4 PEST Analysis
5 Market Characteristics
5.1 Market Dynamics
18.104.22.168 Easy Stem Cell Extraction Method from The Sample
22.214.171.124 Increasing global Birth-rate
126.96.36.199 Potentials of stem cell in treatment of various diseases
188.8.131.52 Increasing investment in Stem Cell Banking
184.108.40.206 Merger and Acquisition
220.127.116.11 High operating cost
18.104.22.168 Lack of acceptance
22.214.171.124 Government Regulation
5.1.4 DRO – Impact Analysis
5.1.5 Key Stakeholders
6 Source Types: Market Size and Analysis
6.1.1 Umbilical Cord Blood and Tissue Banking
6.1.2 Adult Stem Cell Banking
7 Stem Cell Bank Types: Market Size and Analysis
7.1.1 Private Stem Cell Banks
7.1.2 Public Stem Cell Banks
8 Regions: Market Size and Analysis
8.2 North America
8.5 Rest of the World
126.96.36.199 South Africa
9 Competitive Landscape
10 Vendor Profiles
10.1 Esperite N.V.
10.1.2 Business Unit
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategy
10.2 Caladrius Biosciences, Inc.
10.2.2 Business Unit
10.2.3 Business Focus
10.2.4 SWOT Analysis
10.2.5 Business Strategy
10.3 Cryo-Cell International
10.4 China Cord Blood Corporation.
10.4.2 SWOT Analysis
10.4.3 Business Strategy
10.5 StemCyte India Therapeutics Pvt. Ltd.,
10.6 CBR Systems Inc.
10.7 Smart Cell UK
10.11 Cryo-Cell International
10.12 Cryoviva Biotech Pvt Ltd
TABLE 1 THERAPIES USING CORD BLOOD HEMATOPOIETIC STEM CELLS 19
TABLE 2 STEM CELL BANKING MARKET REVENUE BY REGIONS, 2016–2023 ($MILLION) 31
TABLE 3 TOP STEM CELLS BANKS IN INDIA 36
TABLE 4 OTHER PROMINENT VENDORS IN THE MARKET 41
TABLE 5 ESPERITE N.V.: RECENT DEVELOPMENTS 43
TABLE 6 CALADRIUS BIOSCIENCES: RECENT DEVELOPMENTS 48
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.